Systematic review and meta-analysis of the efficacy and safety of electroacupuncture for poststroke dysphagia.

dysphagia electroacupuncture meta-analysis randomized controlled trials stroke systematic review

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2023
Historique:
received: 02 08 2023
accepted: 16 11 2023
medline: 21 12 2023
pubmed: 21 12 2023
entrez: 21 12 2023
Statut: epublish

Résumé

Optimal treatment strategies for post-stroke dysphagia (PSD) remain to be explored. Electroacupuncture (EA) has attracted widespread attention due to its simplicity, cheapness, and safety. However, the efficacy of EA in the treatment of PSD lacks high-level evidence-based medical support. This study aimed to systematically evaluate the clinical value of EA in the treatment of PSD. A total of seven databases were searched for relevant literature. All randomized controlled trials (RCTs) on EA alone or EA combined with other interventions for the treatment of PSD were assessed using the modified Jadad scale. The studies with a score of ≥4 were included. The quality of the included studies was then assessed using the Cochrane Collaboration's tool. The meta-analysis was performed using Rev. Man 5.3 software. Twelve studies involving 1,358 patients were included in the meta-analysis. Meta-analysis results showed that the EA group was superior to the control group in terms of clinical response rate (OR = 2.63, 95% CI = 1.97 to 3.53) and videofluoroscopic swallowing study (VFSS) score (MD = 0.73, 95% CI = 0.29 to 1.16). There was no significant difference between the two groups in the standardized swallowing assessment (SSA) score (MD = -3.11, 95% CI = -6.45 to 0.23), Rosenbek penetration-aspiration scale (PAS) score (MD = -0.68, 95% CI = -2.78 to 1.41), Swallowing Quality of Life (SWAL-QOL) score (MD = 13.24, 95% CI = -7.74 to 34.21), or incidence of adverse events (OR = 1.58, 95% CI = 0.73 to 3.38). This study shows that EA combined with conventional treatment or other interventions can significantly improve the clinical response rate and VFSS score in patients with PSD without increasing adverse reactions.

Identifiants

pubmed: 38125830
doi: 10.3389/fneur.2023.1270624
pmc: PMC10731355
doi:

Types de publication

Systematic Review

Langues

eng

Pagination

1270624

Informations de copyright

Copyright © 2023 Li, Lu, Fu, Li, Yang, Guo, Guo and Huang.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Xuezheng Li (X)

Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

Lijun Lu (L)

Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

Xuefeng Fu (X)

Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

Hao Li (H)

Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

Wen Yang (W)

Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

Hua Guo (H)

Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

Kaifeng Guo (K)

Department of Rehabilitation Medicine, Guangzhou Panyu Central Hospital, Guangzhou Guangdong, China.

Zhen Huang (Z)

Department of Rehabilitation Medicine, Guangzhou Panyu Central Hospital, Guangzhou Guangdong, China.

Classifications MeSH